Simon F. Semus
GlaxoSmithKline (United States) · 22 works · 2,796 citations · h-index 14
Top works
- A Critical Assessment of Docking Programs and Scoring Functions
- HINT: A new method of empirical hydrophobic field calculation for CoMFA
- Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors
- Modeling the Cannabinoid Receptor: A Three-Dimensional Quantitative Structure-Activity Analysis
- Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity
- A computergraphic investigation into the pharmacological role of the THC-cannabinoid phenolic moiety
- The Role of Transmembrane Helix 5 in Agonist Binding to the Human H3 Receptor
- Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases
- NMR Structure of Free RGS4 Reveals an Induced Conformational Change upon Binding Gα
- Pharmacological evaluation of iodo and nitro analogs of Δ8-THC and Δ9-THC
- Perspectives on the Discovery of Small-Molecule Modulators for Epigenetic Processes
- Epidemiology of adenoid cystic carcinoma in the United States.
- 2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic Acid (PD-307243) Causes Instantaneous Current through Human Ether-a-go-go-Related Gene Potassium Channels
- Acylhydrazones as M1/M3 selective muscarinic agonists
- 3D QSAR in modern drug design
- A computergraphic determination of the chemotactic peptide preferred conformation
- Conformationally constrained formyl chemotactic peptides: retrospective analysis and design using molecular graphics
- Synthesis and Modeling Studies of a Potent Conformationally Rigid Muscarinic Agonist: 1-Azabicyclo[2.2.1]heptanespirofuranone
- Characterizing the Role of Thr352 in the Inhibition of the Large Conductance Ca2+-Activated K+ Channels by 1-[1-Hexyl-6-(methyloxy)-1H-indazol-3-yl]-2-methyl-1-propanone
- A computer-aided investigation into the role of hydrogen bonding in the binding conformation of the endo-ethenotetrahydrooripavine, PEO.